GHK-Cu research: how a copper tripeptide moves collagen, genes, and neurons

How GHK-Cu works

GHK-Cu research begins with a paradox of scale: a tripeptide present at nanomolar plasma concentrations produces measurable, reproducible shifts in tissue behavior. In human fibroblast cultures, GHK-Cu stimulated collagen synthesis from 10^-12 to 10^-11 M, peaking near 10^-9 M, independent of any change in cell number ^[1]. That dose-response — onset at picomolar, plateau at nanomolar — is the foundational evidence that GHK liberated from collagen drives local repair rather than acting as a structural building block.

The mechanism is copper-dependent and pleiotropic. The Cu(II) ion enables lysyl-oxidase cross-linking of collagen and elastin and a superoxide-dismutase-like antioxidant activity. The peptide scaffold engages TGF-beta/Smad signaling (pro-remodeling in wounds, anti-fibrotic in excess fibrosis), suppresses NF-kB-driven inflammation, and activates the Nrf2/Keap1/HO-1 antioxidant axis ^[6]. Across these pathways GHK-Cu rebalances matrix metalloproteinases (MMP-2, MMP-9) against their TIMP inhibitors, favoring controlled remodeling over tissue destruction.

Copper Tripeptide-1: The INCI Name for GHK-Cu

Copper Tripeptide-1 is the INCI (International Nomenclature of Cosmetic Ingredients) name for GHK-Cu — the label term used to declare copper-peptide content in skincare. Readers who arrive from a product ingredient list and readers who arrive from a research database are looking at the same molecule: CAS 89030-95-5, molecular formula C14H23CuN6O4+, the glycyl-L-histidyl-L-lysine copper(II) complex. The cosmetic name reflects regulatory framing (a legal cosmetic ingredient), not a different compound; the underlying tripeptide and its copper chelate are identical to the entity described throughout the research literature ^[3].

Copper Peptide Benefits Reported in the Research Literature

The copper peptide benefits documented across the GHK-Cu literature cluster into four research domains. In skin, GHK-Cu stimulates collagen, dermatan and chondroitin sulfate, and decorin synthesis, with placebo-controlled topical trials reporting improved skin density, firmness, fine lines, and wrinkle depth ^[3]. In wound repair, it upregulates VEGF, FGF-2, and matrix proteins while suppressing free radicals and inflammation and chemoattracting repair cells ^[6]. In hair, tissue-remodeling reviews attribute follicle effects to VEGF and FGF-2 angiogenesis ^[4][6]. At the gene level, GHK shifts expression toward repair, antioxidant, and protein-quality-control programs ^[2].

These are research findings, catalogued by domain. The strongest controlled human signal is dermatologic and follicular; the systemic and neuroprotective benefits rest largely on in vitro and rodent models. Each domain below is read with its own provenance, and the gaps are marked, not smoothed over.

What genes GHK-Cu modulates

GHK alters expression of roughly 31.2% of human genes at a 50%-or-greater change threshold, with 59% of affected genes upregulated and 41% suppressed, according to Connectivity Map analyses ^[2]. The strongest single signal is the ubiquitin-proteasome system — the cell's protein-quality-control machinery — with 41 genes up and 1 down. DNA-repair and antioxidant gene sets are also upregulated ^[2].

The often-quoted figure of "~4,000 genes" is an extrapolation. The verified statistic is the 31.2%-at-50%-change table, which reports on the order of 2,100 genes at that threshold; broader-threshold counts inflate the number ^[2]. The gene data derives largely from database analyses that still need protein-level in vivo validation — a meaningful caveat catalogued here in plain sight.